Minutes it takes until the patient is cooperative enough for the procedure
Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients
Brief Summary
The purpose of this study is to determine if intranasal ketamine is equally as effective and safe as intramuscular ketamine for procedural sedation in pediatric patients.
Condition or Disease
- Sedation
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Terminated |
Study results: | No Results Available |
Age: | 2 Years to 17 Years |
Enrollment: | 3 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Treatment |
MaskingQUADRUPLE:
|
Clinical Trial Dates
Start date: | Jan 01, 2011 | |
---|---|---|
Primary Completion: | Jan 01, 2012 | ACTUAL |
Completion Date: | Jan 01, 2012 | ACTUAL |
Study First Posted: | Jul 27, 2010 | ESTIMATED |
Results First Posted: | Jul 02, 2017 | ACTUAL |
Last Updated: | Jun 03, 2017 |
Sponsors / Collaborators
Lead Sponsor:
University of Iowa
Responsible Party:
N/A
Location
Participant Groups
-
No description provided
-
No description provided
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 2 |
Maximum Age: | 17 |
Age Groups: | Child |
Healthy Volunteers: | Yes |
Inclusion Criteria:
* pediatric patients age 2 to 17 years old
* have a laceration of 4 cm on the face or 7 cm on the remainder of the body
* Require procedural sedation to repair the laceration
Exclusion Criteria:
* Patients with abnormal nasal physiology which would not allow for adequate medication delivery
* Unable to have a guardian present to consent on their behalf
* Allergy to ketamine
* Significant cardiac history (myocardial ischemia, heart failure, arrhythmias)
* Presenting with a head injury associated with possible intracranial hypertension
* Pregnancy
* Lacerations that require repair from a consult service
* pediatric patients age 2 to 17 years old
* have a laceration of 4 cm on the face or 7 cm on the remainder of the body
* Require procedural sedation to repair the laceration
Exclusion Criteria:
* Patients with abnormal nasal physiology which would not allow for adequate medication delivery
* Unable to have a guardian present to consent on their behalf
* Allergy to ketamine
* Significant cardiac history (myocardial ischemia, heart failure, arrhythmias)
* Presenting with a head injury associated with possible intracranial hypertension
* Pregnancy
* Lacerations that require repair from a consult service
Primary Outcomes
More Details
NCT Number: | NCT01170247 |
---|---|
Other IDs: | 201006786 |
Study URL: | https://clinicaltrials.gov/study/NCT01170247 |
Last updated: Sep 29, 2023